BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arda-Pirincci P, Oztay F, Bayrak BB, Yanardag R, Bolkent S. Teduglutide, a glucagon-like peptide 2 analogue: a novel protective agent with anti-apoptotic and anti-oxidant properties in mice with lung injury. Peptides 2012;38:238-47. [PMID: 23059393 DOI: 10.1016/j.peptides.2012.09.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Costa BP, Cipriano MA, Gonçalves AC, Abrantes AM, Matafome P, Seiça R, Sarmento-ribeiro AB, Botelho MF, Castro-sousa F. Effects of teduglutide on histological parameters of intestinal anastomotic healing. Eur Surg 2017;49:218-27. [DOI: 10.1007/s10353-017-0478-9] [Reference Citation Analysis]
2 Connor E, Evock-clover C, Wall E, Baldwin R, Santin-duran M, Elsasser T, Bravo D. Glucagon-like peptide 2 and its beneficial effects on gut function and health in production animals. Domestic Animal Endocrinology 2016;56:S56-65. [DOI: 10.1016/j.domaniend.2015.11.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
3 Aksu B, Ayvaz S, Aksu F, Karaca T, Cemek M, Ayaz A, Demirtaş S. Effects of sphingosylphosphorylcholine against oxidative stress and acute lung ınjury ınduced by pulmonary contusion in rats. J Pediatr Surg 2015;50:591-7. [PMID: 25840069 DOI: 10.1016/j.jpedsurg.2014.06.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
4 Su Y, Zhang Z, Li H, Ma J, Sun L, Shao S, Zhang Z, Hölscher C. A GLP-2 Analogue Protects SH-SY5Y and Neuro-2a Cells Against Mitochondrial Damage, Autophagy Impairments and Apoptosis in a Parkinson Model. Drug Res (Stuttg) 2021;71:43-50. [PMID: 33022720 DOI: 10.1055/a-1266-3263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Duan L, Rao X, Braunstein Z, Toomey AC, Zhong J. Role of Incretin Axis in Inflammatory Bowel Disease. Front Immunol 2017;8:1734. [PMID: 29270177 DOI: 10.3389/fimmu.2017.01734] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lei Q, Bi J, Wang X, Jiang T, Wu C, Tian F, Gao X, Wan X, Zheng H. GLP-2 Prevents Intestinal Mucosal Atrophy and Improves Tissue Antioxidant Capacity in a Mouse Model of Total Parenteral Nutrition. Nutrients. 2016;8:pii: E33. [PMID: 26761030 DOI: 10.3390/nu8010033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
7 Brubaker PL. Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1185-210. [DOI: 10.1002/cphy.c170055] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
8 Hansen M, Porosk R, Mahlapuu R, Kairane C, Kilk K, Soomets U. GSH Synthetic Analogue O-Methyl-L-Tyrosinylglutathione Regulates Nrf2-Mediated Expression of GCLc and GCLm. Journal of Chemistry 2019;2019:1-8. [DOI: 10.1155/2019/3841219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
9 Subramanian VS, Teafatiller T, Agrawal A, Kitazawa M, Marchant JS. Effect of Lipopolysaccharide and TNFα on Neuronal Ascorbic Acid Uptake. Mediators Inflamm 2021;2021:4157132. [PMID: 34285658 DOI: 10.1155/2021/4157132] [Cited by in F6Publishing: 1] [Reference Citation Analysis]